DC

Deepak Chaudhary

Director Director DIN 02240918
DIN 02240918 First appointment Jul 2008 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Deepak Chaudhary

Data last updated:

Deepak Chaudhary was a Director at Starex Pharma Private Limited (2008–2009) and Designated Partner at Indus Distributions Llp (2015). The companies operate in Chemicals and Food and Beverages.

DIN 02240918
Primary Designation Director
Industry Chemicals
First Appointment 07 Jul 2008

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Starex Pharma Private Limited U24232DL2005PTC135369
Director07 Jul 20082005Strike Off
Designated Partner15 Jun 20152015Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Starex Pharma Private Limited
Indus Distributions Llp
Premium access

Shareholding and investment profile for Deepak Chaudhary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepak Chaudhary

Deepak Chaudhary was first appointed on 07 Jul 2008 as Director at Starex Pharma Private Limited. The most recent appointment on record is 15 Jun 2015 at Indus Distributions Llp.

Deepak Chaudhary held 2 earlier board appointments: Starex Pharma Private Limited (Director, 07 Jul 2008 to 26 Oct 2009); Indus Distributions Llp (Designated Partner, 15 Jun 2015 to 22 Oct 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available